Skip to main content

Table 1 Baseline socio-demographic, behavioural, and clinical characteristics of ACCESS participants, stratified by gender.

From: Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare

Characteristic Male
n = 341 (63%)
Female
n = 204 (37%)
Odds Ratio (95% CI) pvalue
Age     
   ≥ 24 years 332 (97) 179 (88) 5.2 (2.4-11.3) <0.001
   <24 years 9 (3) 25 (12)   
Aboriginal ethnicity     
   No 249 (73) 111 (54)   
   Yes 92 (27) 93 (46) 2.3 (1.6-3.3) <0.001
Daily heroin use*     
   No 264 (77) 129 (63)   
   Yes 77 (23) 75 (37) 2.0 (1.4-2.9) <0.001
Daily cocaine use*     
   No 227 (67) 126 (62)   
   Yes 114 (33) 78 (38) 1.2 (0.9-1.8) 0.256
Daily crack use*     
   No 271 (79) 142 (70) 1.7 (1.1-2.5) 0.009
   Yes 70 (21) 62 (30)   
Current methadone use     
   No 251 (74) 125 (61)   
   Yes 90 (26) 79 (39) 1.8 (1.2-2.6) 0.003
Any treatment     
   No 140 (41) 75 (37)   
   Yes 201 (59) 129 (63) 1.2 (0.8-1.7) 0.320
Unstable housing     
   No 95 (28) 64 (31)   
   Yes 246 (72) 140 (69) 0.8 (0.6-1.2) 0.383
On ART at baseline     
   No 208 (61) 142 (70)   
   Yes 133 (39) 62 (30) 0.7 (0.5-1.0) 0.042
Viral load (log 10 copies/mL)     
   ≥ 100,000 66 (19) 32 (16) 1.3 (0.8-2.1) 0.281
   <100,000 275 (81) 172 (84)   
CD4+ count (cells/mm 3 )     
   ≥ 200 261 (77) 164 (80) 0.8 (0.5-1.2) 0.294
   <200 80 (23) 40 (20)   
  1. Includes all eligible participants that completed at least one interview between May 1996 and April 2008 and where baseline clinical data was available. *Refers to the six-month period prior to the baseline interview.